Skip to main content
Premium Trial:

Request an Annual Quote

Aetna to Reimburse for Clinical Data Cardiac Test

NEW YORK (GenomeWeb News) – Clinical Data division PGxHealth today said that Aetna would provide coverage for its Familion family of genetic tests that are used for detecting inherited forms of cardiac channelopathies and cardiomyopathies.
The Newton, Mass.-based firm did not provide financial details of the reimbursement, but it noted that with the in-network coverage for Aetna patients, its Familion tests have positive reimbursement policies from private and public insurers covering an estimated 155 million lives. It also noted that PGxHealth is an approved Medicare provider for its genetic testing services and a Medicaid provider in 37 states and the District of Columbia.
The Familion tests detect genetic mutations that can cause cardiac channelopathies and cardiomyopathies, said Clinical Data. The tests can be used by physicians to help guide treatment and reduce the incidence of fatal cardiac events, the firm said.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.